These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36822821)

  • 1. Medications for specific phenotypes of heart failure with preserved ejection fraction classified by a machine learning-based clustering model.
    Sotomi Y; Hikoso S; Nakatani D; Okada K; Dohi T; Sunaga A; Kida H; Sato T; Matsuoka Y; Kitamura T; Komukai S; Seo M; Yano M; Hayashi T; Nakagawa A; Nakagawa Y; Tamaki S; Ohtani T; Yasumura Y; Yamada T; Sakata Y;
    Heart; 2023 Jul; 109(16):1231-1240. PubMed ID: 36822821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
    Martin N; Manoharan K; Thomas J; Davies C; Lumbers RT
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012721. PubMed ID: 29952095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
    Martin N; Manoharan K; Davies C; Lumbers RT
    Cochrane Database Syst Rev; 2021 May; 5(5):CD012721. PubMed ID: 34022072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Prescribing Patterns of Renin-Angiotensin System Blockers and Beta-Blockers on Prognosis of Heart Failure.
    Kim HJ; Jo SH; Lee MH; Seo WW; Choi JO; Ryu KH
    Adv Ther; 2020 Sep; 37(9):3839-3849. PubMed ID: 32676928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of angiotensin receptor blocker at discharge in patients with heart failure with reduced ejection fraction: Korean Acute Heart Failure (KorAHF) registry.
    Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Cho HJ; Lee SE; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Park HY; Cho MC; Oh BH
    Int J Cardiol; 2018 Apr; 257():168-176. PubMed ID: 29506690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
    Gilstrap LG; Fonarow GC; Desai AS; Liang L; Matsouaka R; DeVore AD; Smith EE; Heidenreich P; Hernandez AF; Yancy CW; Bhatt DL
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28189999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
    Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M
    Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic association of medication trajectories with 3-year mortality in heart failure and preserved ejection fraction: findings from the EPICAL2 cohort study.
    Bitar S; Thilly N; Agrinier N
    Eur J Clin Pharmacol; 2021 Oct; 77(10):1569-1581. PubMed ID: 33970296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics, prognosis and treatment response in distinct phenogroups of heart failure with preserved ejection fraction.
    Gu J; Pan JA; Lin H; Zhang JF; Wang CQ
    Int J Cardiol; 2021 Jan; 323():148-154. PubMed ID: 32860842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of left ventricular ejection fraction on the effect of renin-angiotensin system blockers after an episode of acute heart failure: From the KCHF Registry.
    Yoshikawa Y; Tamaki Y; Morimoto T; Yaku H; Yamamoto E; Inuzuka Y; Ozasa N; Kitai T; Nagao K; Sato Y; Kondo H; Tamura T; Nakagawa Y; Kuwahara K; Kato T; Kimura T
    PLoS One; 2020; 15(9):e0239100. PubMed ID: 32925953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation.
    Ahn MS; Yoo BS; Son JW; Park YJ; Lee HY; Jeon ES; Kang SM; Choi DJ; Kim KH; Cho MC; Kim SY; Kang DR; Go TH
    J Korean Med Sci; 2021 Oct; 36(40):e252. PubMed ID: 34664798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF.
    Jering KS; Zannad F; Claggett B; Mc Causland FR; Ferreira JP; Desai A; Barkoudah E; McMurray JJV; Pfeffer MA; Solomon SD
    JACC Heart Fail; 2021 Jan; 9(1):13-24. PubMed ID: 33189633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.
    Lund LH; Benson L; Dahlström U; Edner M
    JAMA; 2012 Nov; 308(20):2108-17. PubMed ID: 23188027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and prognostic value of monoclonal gammopathy in heart failure patients with preserved ejection fraction: A prospective study.
    Devesa A; Rodríguez Olleros C; Kaçi X; Askari E; Camblor Blasco A; Pello Lázaro AM; Gómez Talavera S; Gómez Octavio J; Lapeña G; Navarro F; Tuñón J; Ibáñez B; Aceña Á
    Cardiol J; 2022; 29(2):216-227. PubMed ID: 32329041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of heart failure phenotypes and current use of therapies in primary care: results from a nationwide study.
    Jensen J; Poulsen MK; Petersen PW; Gerdes B; Rossing K; Schou M
    ESC Heart Fail; 2023 Jun; 10(3):1745-1756. PubMed ID: 36852608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine Learning Methods Improve Prognostication, Identify Clinically Distinct Phenotypes, and Detect Heterogeneity in Response to Therapy in a Large Cohort of Heart Failure Patients.
    Ahmad T; Lund LH; Rao P; Ghosh R; Warier P; Vaccaro B; Dahlström U; O'Connor CM; Felker GM; Desai NR
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29650709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers in Acute Coronary Syndrome and Preserved Ventricular Ejection Fraction.
    Cespón-Fernández M; Raposeiras-Roubín S; Abu-Assi E; Pousa IM; Queija BC; Paz RJC; Erquicia PD; Rodríguez LMD; Rodríguez EL; Busto MC; Barbeira SF; Romo AÍ
    Angiology; 2020 Nov; 71(10):886-893. PubMed ID: 32757765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study).
    Gupta P; Voors AA; Patel P; Lane D; Anker SD; Cleland JGF; Dickstein K; Filippatos G; Lang CC; van Veldhuisen DJ; Metra M; Zannad F; Samani NJ; Jones DJL; Squire IB; Ng LL
    Eur J Heart Fail; 2021 Jul; 23(7):1182-1190. PubMed ID: 33759308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.